Komatsu, Y., Doi, T., Sawaki, A., Kanda, T., Yamada, Y., Kuss, I., . . . Nishida, T. (2015). Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: A subgroup analysis evaluating Japanese patients in the phase III GRID trial. Int J Clin Oncol.
Citação norma ChicagoKomatsu, Yoshito, Toshihiko Doi, Akira Sawaki, Tatsuo Kanda, Yasuhide Yamada, Iris Kuss, George D. Demetri, and Toshirou Nishida. "Regorafenib for Advanced Gastrointestinal Stromal Tumors Following Imatinib and Sunitinib Treatment: A Subgroup Analysis Evaluating Japanese Patients in the Phase III GRID Trial." Int J Clin Oncol 2015.
Citação norma MLAKomatsu, Yoshito, et al. "Regorafenib for Advanced Gastrointestinal Stromal Tumors Following Imatinib and Sunitinib Treatment: A Subgroup Analysis Evaluating Japanese Patients in the Phase III GRID Trial." Int J Clin Oncol 2015.